Quad Technologies, a life sciences startup with IDEA, competed in this year’s MassChallenge, walking away with $45K and thousands more in in-kind services. After competing against 1,200 startups that applied to the accelerator program, Quad was accepted into the round of 128 finalists. The venture then advanced to the top 26, and became eligible for $1 million in cash and more than $10 million in in-kind support.
Quad Technologies is addressing the issues of harvesting stem cells. Sean Kevlahan, founder of Quad, is currently developing a unique, dissolvable hydrogel called QuickGel™, which separates stem cells from solutions in the harvesting process to prevent them being damaged or destroyed.
Kevlahan plans on using the funding from MassChallenge for direct costs in the experimental stage to “help gain a better understanding of our manufacturing process allowing us to successfully scale our production.” Quad also received travel points provided by American Airlines.
“We thoroughly enjoyed being a part of MassChallenge. The biggest take-away was the networking amongst fellow entrepreneurs and industry leaders,” says Kevlahan. “In addition, the mentorship program was truly an invaluable experience.”
Quad Technologies’ next step is to finish evaluation studies, and in 2014, start alpha and beta testing their stem cell harvesting kit within the stem cell community.
Kevin Walther is the Communications Officer for IDEA: Northeastern University’s Venture Accelerator. Follow IDEA at @IDEANEU.